{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:42:03Z","timestamp":1788997323253,"version":"build-2803163510"},"reference-count":118,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00083","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:03:54Z","timestamp":1497953034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["Current Therapeutic Approach to Hypertrophic Scars"],"prefix":"10.3389","volume":"4","author":[{"given":"Zrinka Bukvi\u0107","family":"Mokos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria","family":"Jovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovorka","family":"Grgurevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Dumi\u0107-\u010cule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kre\u0161imir","family":"Kostovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"\u010ceovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","article-title":"Cytokine mediated tissue fibrosis","volume":"1832","author":"Borthwick","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1524-475X.2009.00543.x","article-title":"Human skin wounds: a major and snowballing threat to public health and the economy","volume":"17","author":"Sen","year":"2009","journal-title":"Wound Repair Regen"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00403-006-0651-7","article-title":"Quality of life of patients with keloid and hypertrophic scarring","volume":"297","author":"Bock","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1152\/physrev.00031.2002","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clindermatol.2006.09.007","article-title":"Pathophysiology of acute wound healing","volume":"25","author":"Li","year":"2007","journal-title":"Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/wound.2013.0485","article-title":"Extracellular matrix reorganization during wound healing and its impact on abnormal scarring","volume":"4","author":"Xue","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3160001","article-title":"Collagen fibril formation","volume":"316","author":"Kadler","year":"1996","journal-title":"Biochem J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/1523-1747.ep12627386","article-title":"The histiotypic organization of the hypertrophic scar in humans","volume":"59","author":"Linares","year":"1972","journal-title":"J Invest Dermatol"},{"key":"B10","first-page":"205","article-title":"Collagen types in early phases of wound healing in children","volume":"144","author":"Gay","year":"1977","journal-title":"Acta Chir Scand"},{"key":"B11","doi-asserted-by":"publisher","first-page":"s10","DOI":"10.1111\/j.1524-475X.2011.00708.x","article-title":"Mechanisms of pathological scarring: role of myofibroblasts and current developments","volume":"19","author":"Sarrazy","year":"2011","journal-title":"Wound Repair Regen"},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.retram.2016.09.003","article-title":"The role of myofibroblasts in wound healing","volume":"64","author":"Hinz","year":"2016","journal-title":"Curr Res Transl Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1755-1536-5-s1-s5","article-title":"The myofibroblast, multiple origins for major roles in normal and pathological tissue repair","volume":"5","author":"Micallef","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.biopha.2016.09.010","article-title":"Growth factor pathways in hypertrophic scars: molecular pathogenesis and therapeutic implications","volume":"84","author":"Lian","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1189\/jlb.4MR0316-102R","article-title":"Angiogenesis and wound repair: when enough is enough","volume":"100","author":"DiPietro","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.12688\/f1000research.8190.1","article-title":"The myofibroblast in wound healing and fibrosis: answered and unanswered questions","volume":"5","author":"Bochaton-Piallat","year":"2016","journal-title":"F1000Research"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/cbic.201200298","article-title":"Chemical biology for understanding matrix metalloproteinase function","volume":"13","author":"Knapinska","year":"2012","journal-title":"Chembiochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.biocel.2007.10.024","article-title":"Metalloproteinases and their inhibitors: regulators of wound healing","volume":"40","author":"Gill","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00006534-199910000-00031","article-title":"On the nature of hypertrophic scars and keloids: a review","volume":"104","author":"Niessen","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/1523-1747.ep12343658","article-title":"Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1","volume":"106","author":"Ghahary","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1096\/fj.06-7860com","article-title":"Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8)","volume":"21","author":"Gutierrez-Fernandez","year":"2007","journal-title":"FASEB J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.matbio.2007.05.004","article-title":"The bone morphogenetic protein 1\/Tolloid-like metalloproteinases","volume":"26","author":"Hopkins","year":"2007","journal-title":"Matrix Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2015.02.006","article-title":"BMP-1\/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling","volume":"4","author":"Vadon-Le Goff","year":"2015","journal-title":"Matrix Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.271.5247.360","article-title":"Bone morphogenetic protein-1: the type I procollagen C-proteinase","volume":"271","author":"Kessler","year":"1996","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/bdrc.20060","article-title":"Developmental roles of the BMP1\/TLD metalloproteinases","volume":"78","author":"Ge","year":"2006","journal-title":"Birth Defects Res C Embryo Today"},{"key":"B27","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1242\/dev.122.11.3587","article-title":"Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid","volume":"122","author":"Suzuki","year":"1996","journal-title":"Development"},{"key":"B28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.matbio.2016.06.004","article-title":"BMP1-like proteinases are essential to the structure and wound healing of skin","volume":"56","author":"Muir","year":"2016","journal-title":"Matrix Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1681\/asn.2010070722","article-title":"Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis","volume":"22","author":"Grgurevic","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbrc.2011.03.109","article-title":"Bone morphogenetic protein (BMP)1-3 enhances bone repair","volume":"408","author":"Grgurevic","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.burns.2006.08.018","article-title":"Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts","volume":"33","author":"Zhang","year":"2007","journal-title":"Burns"},{"key":"B32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.burns.2008.08.021","article-title":"Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts","volume":"35","author":"Zhang","year":"2009","journal-title":"Burns"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3892\/etm.2016.3591","article-title":"Decorin reduces hypertrophic scarring through inhibition of the TGF-beta1\/Smad signaling pathway in a rat osteomyelitis model","volume":"12","author":"Wang","year":"2016","journal-title":"Exp Ther Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"18157","DOI":"10.1074\/jbc.M312609200","article-title":"Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate alpha2beta1 integrin, and recruit alphavbeta3 instead of alpha5beta1 integrin","volume":"279","author":"Zoppi","year":"2004","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-1536-4-21","article-title":"Plasma and cellular fibronectin: distinct and independent functions during tissue repair","volume":"4","author":"To","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.aai8792","article-title":"Regeneration of fat cells from myofibroblasts during wound healing","volume":"355","author":"Plikus","year":"2017","journal-title":"Science"},{"key":"B37","first-page":"7631","article-title":"Cross-talk between TGF-beta\/Smad pathway and Wnt\/beta-catenin pathway in pathological scar formation","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.burns.2014.02.011","article-title":"Up-to-date approach to manage keloids and hypertrophic scars: a useful guide","volume":"40","author":"Arno","year":"2014","journal-title":"Burns"},{"key":"B39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/wound.2012.0406","article-title":"Critical role of transforming growth factor beta in different phases of wound healing","volume":"2","author":"Pakyari","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","article-title":"Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring","volume":"108","author":"Shah","year":"1995","journal-title":"J Cell Sci"},{"key":"B41","first-page":"8551","article-title":"Uighur medicine abnormal savda munzip (ASMq) suppresses expression of collagen and TGF-beta1 with concomitant induce Smad7 in human hypertrophic scar fibroblasts","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb03205.x","article-title":"Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta","volume":"995","author":"Roberts","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/exd.12665","article-title":"Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-beta\/Smad pathway","volume":"24","author":"Bai","year":"2015","journal-title":"Exp Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/bph.13460","article-title":"Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars","volume":"173","author":"Bai","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/exd.13014","article-title":"Prostaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo","volume":"25","author":"Zhao","year":"2016","journal-title":"Exp Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1111\/j.1524-475X.2007.00219.x","article-title":"Cellular and molecular pathology of HTS: basis for treatment","volume":"15","author":"Armour","year":"2007","journal-title":"Wound Repair Regen"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2011.05.055","article-title":"Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation","volume":"66","author":"Profyris","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1468-3083.2011.04200.x","article-title":"Extracellular matrix molecules implicated in hypertrophic and keloid scarring","volume":"26","author":"Sidgwick","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1524-4725.2008.34406.x","article-title":"Hypertrophic scars and keloids\u2014a review of their pathophysiology, risk factors, and therapeutic management","volume":"35","author":"Wolfram","year":"2009","journal-title":"Dermatol Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1524-4725.1999.98257.x","article-title":"Keloids and hypertrophic scars","volume":"25","author":"English","year":"1999","journal-title":"Dermatol Surg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mehy.2016.09.024","article-title":"Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis \u2013 keloids and hypertrophic scars may be vascular disorders","volume":"96","author":"Ogawa","year":"2016","journal-title":"Med Hypotheses"},{"key":"B52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bjps.2015.11.015","article-title":"Currently known risk factors for hypertrophic skin scarring: a review","volume":"69","author":"Butzelaar","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00006534-200208000-00031","article-title":"International clinical recommendations on scar management","volume":"110","author":"Mustoe","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/dsu.0000000000000049","article-title":"Updated international clinical recommendations on scar management: part 1 \u2013 evaluating the evidence","volume":"40","author":"Gold","year":"2014","journal-title":"Dermatol Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"150e","DOI":"10.1097\/01.prs.0000191977.51206.43","article-title":"Hypertrophic response and keloid diathesis: two very different forms of scar","volume":"116","author":"Burd","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1524-475X.2009.00533.x","article-title":"Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis","volume":"17","author":"Verhaegen","year":"2009","journal-title":"Wound Repair Regen"},{"key":"B57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.mop.0000236389.41462.ef","article-title":"Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management","volume":"18","author":"Slemp","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00000372-200410000-00006","article-title":"Histopathological differential diagnosis of keloid and hypertrophic scar","volume":"26","author":"Lee","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"B59","first-page":"105","article-title":"Morphological and immunochemical differences between keloid and hypertrophic scar","volume":"145","author":"Ehrlich","year":"1994","journal-title":"Am J Pathol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"165s","DOI":"10.1097\/prs.0000000000002647","article-title":"Evidence-based scar management: how to improve results with technique and technology","volume":"138","author":"Khansa","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"B61","first-page":"20","article-title":"Innovative therapies in the treatment of keloids and hypertrophic scars","volume":"3","author":"Viera","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ca.22278","article-title":"The tangled web of Langer\u2019s lines","volume":"27","author":"Carmichael","year":"2014","journal-title":"Clin Anat"},{"key":"B63","first-page":"275","article-title":"Scars. Can they be minimised?","volume":"27","author":"Burke","year":"1998","journal-title":"Aust Fam Physician"},{"key":"B64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.burns.2008.07.016","article-title":"Prevention and curative management of hypertrophic scar formation","volume":"35","author":"Bloemen","year":"2009","journal-title":"Burns"},{"key":"B65","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PRS.0b013e3181c82dd5","article-title":"The most current algorithms for the treatment and prevention of hypertrophic scars and keloids","volume":"125","author":"Ogawa","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"B66","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/wound.2015.0625","article-title":"The use of silicone adhesives for scar reduction","volume":"4","author":"Bleasdale","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00266-006-0218-1","article-title":"The efficacy of topical silicone gel elastomers in the treatment of hypertrophic scars, keloid scars, and post-laser exfoliation erythema","volume":"31","author":"Chernoff","year":"2007","journal-title":"Aesthetic Plast Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.burns.2004.06.018","article-title":"Pressure garments for use in the treatment of hypertrophic scars \u2013 a review of the problems associated with their use","volume":"32","author":"Macintyre","year":"2006","journal-title":"Burns"},{"key":"B69","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/moo.0000000000000268","article-title":"Advances in scar management: prevention and management of hypertrophic scars and keloids","volume":"24","author":"Del Toro","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/ddg.13027","article-title":"Current options for the treatment of pathological scarring","volume":"14","author":"Poetschke","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"B71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1684\/ejd.2014.2356","article-title":"Management of scars: updated practical guidelines and use of silicones","volume":"24","author":"Meaume","year":"2014","journal-title":"Eur J Dermatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2340\/00015555-0154","article-title":"Effect of UV irradiation on cutaneous cicatrices: a randomized, controlled trial with clinical, skin reflectance, histological, immunohistochemical and biochemical evaluations","volume":"87","author":"Due","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00004630-199901001-00011","article-title":"Scar assessment: current problems and future solutions","volume":"20","author":"Powers","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"B74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0036-1597684","article-title":"Applying a visual assessment tool to facial linear scars","volume":"33","author":"Collins","year":"2017","journal-title":"Facial Plast Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0846.2008.00327.x","article-title":"Scar assessment scales: a dermatologic overview","volume":"15","author":"Idriss","year":"2009","journal-title":"Skin Res Technol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/srt.12334","article-title":"Measurements of scar properties by SkinFibroMeter(R), SkinGlossMeter(R), and Mexameter(R) and comparison with Vancouver Scar Scale","volume":"66","author":"Seo","year":"2016","journal-title":"Skin Res Technol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1684\/ejd.2016.2873","article-title":"Objective and subjective treatment evaluation of scars using optical coherence tomography, sonography, photography, and standardised questionnaires","volume":"26","author":"Reinholz","year":"2016","journal-title":"Eur J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/dss.0000000000000698","article-title":"Current and emerging options for documenting scars and evaluating therapeutic progress","volume":"43","author":"Poetschke","year":"2017","journal-title":"Dermatol Surg"},{"key":"B79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/iwj.12629","article-title":"Efficacy and safety of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis","volume":"14","author":"Ren","year":"2017","journal-title":"Int Wound J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00266-006-0253-y","article-title":"Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods","volume":"31","author":"Atiyeh","year":"2007","journal-title":"Aesthetic Plast Surg"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1524-4725.2007.33280.x","article-title":"A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management","volume":"33","author":"Berman","year":"2007","journal-title":"Dermatol Surg"},{"key":"B82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00266-007-9030-9","article-title":"Evolution of silicone therapy and mechanism of action in scar management","volume":"32","author":"Mustoe","year":"2008","journal-title":"Aesthetic Plast Surg"},{"key":"B83","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00266-005-0122-0","article-title":"Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report","volume":"31","author":"Signorini","year":"2007","journal-title":"Aesthetic Plast Surg"},{"key":"B84","doi-asserted-by":"publisher","first-page":"251","DOI":"10.12968\/jowc.2007.16.6.27070","article-title":"The effects of onion extract on hypertrophic and keloid scars","volume":"16","author":"Hosnuter","year":"2007","journal-title":"J Wound Care"},{"key":"B85","first-page":"176","article-title":"The prophylactic use of a topical scar gel containing extract of Allium cepae, allantoin, and heparin improves symptoms and appearance of cesarean-section scars compared with untreated scars","volume":"13","author":"Ocampo-Candiani","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"B86","first-page":"347","article-title":"Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo","volume":"25","author":"Cho","year":"2010","journal-title":"Int J Mol Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/01.TA.0000114087.46566.EB","article-title":"Suppression of transforming growth factor beta\/Smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars","volume":"57","author":"Phan","year":"2004","journal-title":"J Trauma"},{"key":"B88","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/01.PRS.0000153823.52784.7E","article-title":"Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod)","volume":"115","author":"Prado","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"B89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.fsc.2011.06.008","article-title":"Topical modalities for treatment and prevention of postsurgical hypertrophic scars","volume":"19","author":"Foo","year":"2011","journal-title":"Facial Plast Surg Clin North Am"},{"key":"B90","first-page":"253","article-title":"Management of keloids and hypertrophic scars","volume":"80","author":"Juckett","year":"2009","journal-title":"Am Fam Physician"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.bjps.2013.06.004","article-title":"A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro","volume":"66","author":"Huang","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B92","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-4632.2004.02570.x","article-title":"Hypertrophic and keloidal scars: an approach to polytherapy","volume":"44","author":"Boutli-Kasapidou","year":"2005","journal-title":"Int J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1524-4725.1999.08165.x","article-title":"Treatment of inflamed hypertrophic scars using intralesional 5-FU","volume":"25","author":"Fitzpatrick","year":"1999","journal-title":"Dermatol Surg"},{"key":"B94","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1524-4725.2006.32195.x","article-title":"New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars","volume":"32","author":"Asilian","year":"2006","journal-title":"Dermatol Surg"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol Surg"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archotol.1990.01870100053011","article-title":"Intralesional interferon gamma treatment for keloids and hypertrophic scars","volume":"116","author":"Larrabee","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1089\/107999099312876","article-title":"The antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds","volume":"19","author":"Takeuchi","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CCID.S35252","article-title":"Management of keloids and hypertrophic scars: current and emerging options","volume":"6","author":"Gauglitz","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1524-4725.2006.32225.x","article-title":"Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars","volume":"32","author":"Naeini","year":"2006","journal-title":"Dermatol Surg"},{"key":"B100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1473-2165.2008.00360.x","article-title":"Treatment of keloids and hypertrophic scars using bleom","volume":"7","author":"Aggarwal","year":"2008","journal-title":"J Cosmet Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.burns.2013.09.029","article-title":"Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids","volume":"40","author":"Ahuja","year":"2014","journal-title":"Burns"},{"key":"B102","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4103\/0378-6323.42899","article-title":"Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids","volume":"74","author":"Margaret Shanthi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bjps.2012.09.012","article-title":"Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study","volume":"66","author":"Ziade","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B104","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00266-011-9690-3","article-title":"Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar","volume":"35","author":"Xiao","year":"2011","journal-title":"Aesthetic Plast Surg"},{"key":"B105","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast Surg"},{"key":"B106","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1534734608322983","article-title":"Avotermin: a novel antiscarring agent","volume":"7","author":"Durani","year":"2008","journal-title":"Int J Low Extrem Wounds"},{"key":"B107","doi-asserted-by":"publisher","first-page":"s38","DOI":"10.1111\/j.1524-475X.2011.00711.x","article-title":"Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring","volume":"19","author":"Occleston","year":"2011","journal-title":"Wound Repair Regen"},{"key":"B108","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaad.2011.08.035","article-title":"Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures","volume":"66","author":"Tziotzios","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.burns.2010.04.014","article-title":"12-Year within-wound study of the effectiveness of custom pressure garment therapy","volume":"36","author":"Engrav","year":"2010","journal-title":"Burns"},{"key":"B110","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bjps.2007.10.052","article-title":"The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis","volume":"62","author":"Anzarut","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B111","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/BCR.0b013e3181db52a7","article-title":"A randomized clinical trial to study the effect of silicone gel dressing and pressure therapy on posttraumatic hypertrophic scars","volume":"31","author":"Li-Tsang","year":"2010","journal-title":"J Burn Care Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/archderm.138.4.475","article-title":"Release and activation of matrix metalloproteinase-9 during in vitro mechanical compression in hypertrophic scars","volume":"138","author":"Reno","year":"2002","journal-title":"Arch Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0305-4179(00)00101-7","article-title":"Effects of mechanical compression on hypertrophic scars: prostaglandin E2 release","volume":"27","author":"Reno","year":"2001","journal-title":"Burns"},{"key":"B114","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1529-8019.2012.01456.x","article-title":"Intralesional cryosurgery and intralesional steroid injection: a good combination therapy for treatment of keloids and hypertrophic scars","volume":"25","author":"Weshahy","year":"2012","journal-title":"Dermatol Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1272\/jnms.78.68","article-title":"Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial\/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction","volume":"78","author":"Ogawa","year":"2011","journal-title":"J Nippon Med Sch"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1097\/gox.0000000000000231","article-title":"Nd:YAG laser treatment for keloids and hypertrophic scars: an analysis of 102 cases","volume":"2","author":"Koike","year":"2014","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B117","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1365-2133.2011.10492.x","article-title":"Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review","volume":"165","author":"Vrijman","year":"2011","journal-title":"Br J Dermatol"},{"key":"B118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0305-4179(02)00280-2","article-title":"Pulsed dye laser treatment of burn scars. Alleviation or irritation?","volume":"29","author":"Allison","year":"2003","journal-title":"Burns"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00083\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T21:49:57Z","timestamp":1659131397000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00083\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":118,"alternative-id":["10.3389\/fmed.2017.00083"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00083","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"article-number":"83"}}